Chief Financial Officer
Michelle Talarico, Chief Financial Officer, joined Biosero in 2022. Michelle has more than eighteen years of experience in finance roles. As Chief Financial Officer, Michelle is responsible for all aspects of Biosero’s global finances.
Previously, Michelle served as Vice President of Finance at eMolecules, a platform that provides direct access to a vast collection of readily available advanced chemical intermediaries. In 2021, Avista Capital Partners, a leading private equity firm focused exclusively on healthcare, agreed to invest in eMolecules. Prior to that, Michelle served as Controller and Finance Manager at MeLLmo, a provider of mobile business intelligence, where she was responsible for managing all accounting functions for the US corporation and foreign subsidiaries. MeLLmo was acquired by SAP in 2016. Prior to that, she served in many financial and accounting consulting roles targeted around assisting venture-backed and start-up companies through growth phases.
Michelle holds a B.A. in Accounting from Point Loma Nazarene University.